TriSalus Life Sciences Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
16.00
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
4
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-0.37
|
-0.40
|
-0.03
|
-8.77%
|
|
2024-06-30
|
-0.46
|
-0.21
|
0.25
|
54.35%
|
|
2024-03-31
|
-0.65
|
-0.60
|
0.05
|
7.69%
|
|
2023-12-31
|
-0.69
|
-1.56
|
-0.87
|
-126.09%
|
|
2023-09-30
|
0.00
|
-0.13
|
0.00
|
0.00%
|
|
2023-06-30
|
0.00
|
-0.12
|
0.00
|
0.00%
|
|
2023-03-31
|
0.00
|
-0.05
|
0.00
|
0.00%
|
|
2022-12-31
|
0.00
|
-0.01
|
-0.01
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-1.21
|
|
2023-12-31
|
-1.87
|
|
2022-12-31
|
0.18
|
|
2021-12-31
|
0.15
|